19-November-2026
Recently published CDSCO committee minutes document the review of late-stage drug trial protocols. That review is one step in producing evidence doctors can use. The Clinical Trials Registry–India records studies before enrolment, and the World Health Organization recommends posting key outcomes in the relevant registry within 12 months of completion. Can a clinician or patient find the results when a study falls short of its objective?
Registration records what researchers set out to study. Results reporting shows what they found. When favourable studies are easier to find than inconclusive ones, doctors and trial designers can form a distorted picture of the evidence. Participants who contributed their time and accepted risk also have a reasonable interest in knowing what their participation taught researchers.
Sponsors should assign responsibility for results disclosure before the trial begins, including where to post a summary, how to protect participant privacy and who checks that reported outcomes match the registered plan. Research institutions and ethics committees should follow up on completed studies and ask for evidence of public reporting. Funders can publish aggregate figures for studies whose results are available and those still outstanding.
Regulators should explore a common public reporting route that links a trial’s registration number to its summary results. The credibility of India’s research will grow when unfavourable results are as easy to find as favourable ones.















